They promote tumor growth by remodeling the ECM to facilitate invasion, secreting pro-tumorigenic factors such as IL-6 and neuregulin 1 (NRG1) that enhance proliferation and therapy resistance, as well as fostering an immunosuppressive “cold” microenvironment. This evidence concerns the gene NRG1 and neoplasm.